Leading clinicians from across the world are coming together for a  Joint Symposium on evidence based use of T3+T4 combinations for treating hypothyroidism.

The event will take place on Sunday 3rd November 2019, in both London and Chicago, with participants in both locations sharing information and debate.

It has been jointly organised by the American Thyroid Association® (ATA®), the British Thyroid Association (BTA) and the European Thyroid Association (ETA).

The Thyroid Trust is a member of Thyroid Cancer Alliance which gives us access to WECAN, the Workgroup of European Cancer Patient Advocacy Networks. Earlier this year we were fortunate to be able to send a representative to the WECAN Academy in Frankfurt. You can read our report of the course, on an earlier blog post, here.
 
WECAN is now planning its first WECAN Science Academy in early 2020 with three aims: